Abbott Laboratories stock falls 2.32 percent below yearly high effects? no

Published on 09/25/2026 at 13:39 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Abbott Laboratories stock traded at USD 101.09 on September 24, 2026, while analysts set an average target of USD 120.26. Q2 EPS reached USD 1.31 against USD 1.28 consensus.

Modernes Diagnostik-Labor Abbott Laboratories US0028241000 — Abbott Laboratories US0028241000 zeigt modernes Diagnostik-Labor mit Wissenschaftlern in weißen Laborkitteln an Analysesystemen, Illustration mit AI erstellt.

Abbott Laboratories (ISIN US0028241000) stock was trading at USD 101.09 on the NYSE on September 24, 2026, down 2.32 percent from the previous close of USD 103.49. The latest analyst average target stood at USD 120.26, putting the market view above the quoted share price.

Second quarter beat estimates

MarketBeat reported that Abbott's second-quarter results released on July 16, 2026, included quarterly EPS of USD 1.31, which exceeded the USD 1.28 consensus estimate by USD 0.03. Revenue reached USD 12.59 billion against a USD 12.52 billion estimate, while revenue increased 13.0 percent from the year-earlier quarter.

The same release showed full-year 2026 EPS guidance of USD 5.45 to USD 5.60 and third-quarter guidance of USD 1.380 to USD 1.46. The figures give the stock a measurable earnings floor, but the latest quote remains below the average analyst target.

Targets remain above the quote

Analyst positioning provides the clearest comparison for investors. Investing.com listed an average 12-month target of USD 120.26 on September 24, 2026, alongside 22 buy ratings, 5 hold ratings and 0 sell ratings among 27 analysts.

Individual targets also show a wide range of expectations. TD Cowen maintained a USD 135.00 target on August 21, 2026, while UBS maintained USD 125.00 on July 28, 2026, according to the same analyst table. The target dispersion matters because Abbott's 52-week range was USD 81.97 to USD 135.45.

Stock trades below yearly high

Abbott's market capitalization was USD 174,924,455,075 on September 24, 2026, with volume of 6,167,333 shares. The USD 101.09 quote stood USD 34.36 below the 52-week high of USD 135.45, while the latest quarter produced USD 12.59 billion in revenue.